The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A pilot study of sirolimus (S) in subjects with Cowden syndrome (CS) with germ-line mutations in PTEN.
Takefumi Komiya
No relevant relationships to disclose
Gideon Michael Blumenthal
No relevant relationships to disclose
Marc S. Ballas
Employment or Leadership Position - Bristol-Myers Squibb
Consultant or Advisory Role - ImClone Systems; Lilly
Stock Ownership - Abbott Laboratories (I); Bristol-Myers Squibb; Novartis
Honoraria - ImClone Systems; Lilly
Research Funding - ImClone Systems; Lilly
Roopa Dechowdhury
No relevant relationships to disclose
Michell Manu
No relevant relationships to disclose
Suzanne Fioravanti
No relevant relationships to disclose
Thomas J Hornyak
No relevant relationships to disclose
Stephen Wank
No relevant relationships to disclose
Douglas Weinstein
No relevant relationships to disclose
Jennifer Morris
No relevant relationships to disclose
Stephen M. Hewitt
No relevant relationships to disclose
Regan Memmott
No relevant relationships to disclose
Phillip A. Dennis
No relevant relationships to disclose
Betsy Morrow
No relevant relationships to disclose